Valuation: Middle East Pharmaceutical Industries Company

Market Cap 2.14B 571M 510M 468M 426M 798M 54.08B 814M 5.59B 2.25B 28.54B 2.1B 90.15B P/E 2024
30.5x
P/E 2025 22.9x
Enterprise Value 2.17B 579M 517M 474M 432M 809M 54.82B 825M 5.67B 2.28B 28.93B 2.13B 91.39B EV / Sales 2024
6.29x
EV / Sales 2025 4.89x
Free-Float
46.88%
Yield 2024
1.64%
Yield 2025 2.18%
1 day+2.08%
1 week+2.85%
Current month+0.08%
1 month-2.31%
3 months+5.06%
6 months+2.77%
Current year-3.61%
1 week 59.2
Extreme 59.2
61.8
1 month 55.6
Extreme 55.6
64.7
Current year 53.89
Extreme 53.885712
68.51
1 year 53.89
Extreme 53.885712
75.2
3 years 51.54
Extreme 51.542856
112.91
5 years 51.54
Extreme 51.542856
112.91
10 years 51.54
Extreme 51.542856
112.91
Manager TitleAgeSince
Chief Executive Officer 45 05/09/2018
Director of Finance/CFO - 11/03/2024
Chief Tech/Sci/R&D Officer 51 01/01/2023
Director TitleAgeSince
Chairman 54 10/04/2022
Director/Board Member 45 13/09/2023
Director/Board Member 45 10/04/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.08%+2.85%-18.80% - 560M
+0.57%+10.84%+58.48%+150.23% 1,257B
-0.30%+0.57%+45.10%+78.58% 651B
-0.18%+0.81%+36.21%+104.16% 510B
-1.65%-1.88%+50.87%+65.02% 388B
-2.21%+2.38%+76.02%+40.45% 366B
+0.02%+2.27%+32.36%+58.03% 303B
-0.40%+8.08%+12.08%+34.94% 288B
-0.26%+3.75%+56.86%+72.22% 252B
-0.21%+7.25%+39.80%+109.12% 211B
Average -0.24%+4.37%+38.90%+79.19% 422.72B
Weighted average by Cap. -0.28%+5.30%+48.47%+95.13%

Financials

2024 2025
Net sales 394M 105M 93.73M 86.01M 78.24M 147M 9.94B 150M 1.03B 414M 5.25B 386M 16.57B 460M 123M 110M 101M 91.44M 171M 11.62B 175M 1.2B 484M 6.13B 451M 19.36B
Net income 79.85M 21.28M 18.99M 17.43M 15.86M 29.73M 2.01B 30.32M 208M 83.92M 1.06B 78.15M 3.36B 97.01M 25.85M 23.08M 21.18M 19.26M 36.12M 2.45B 36.84M 253M 102M 1.29B 94.94M 4.08B
Net Debt 42.83M 11.41M 10.19M 9.35M 8.51M 15.95M 1.08B 16.26M 112M 45.02M 570M 41.92M 1.8B 29.47M 7.85M 7.01M 6.43M 5.85M 10.97M 743M 11.19M 76.85M 30.98M 392M 28.84M 1.24B
Projected Income Statement - Annual - Middle East Pharmaceutical Industries Company
Logo Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The Company develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Employees
731
Date Price Change Volume
04/11/26 SAR 61.25 +2.08% 55,175
02/11/26 SAR 60.00 +1.35% 150,650
01/11/26 SAR 59.20 -3.27% 56,647
29/10/26 SAR 61.20 +0.41% 45,471
28/10/26 SAR 60.95 +2.35% 73,733
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - Middle East Pharmaceutical Industries Company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
60.00SAR
Average target price
146.40SAR
Spread / Average Target
+144.00%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Middle East Pharmaceutical Industries Company
  1. Stock Market
  2. Stocks
  3. 4016 Stock